SpringWorks Therapeutics Inc. (SWTX) – FDA
-
SpringWorks Therapeutics (SWTX) Reports Rolling Submission of New Drug Application for Mirdametinib
-
SpringWorks Therapeutics (SWTX) Granted EMA Validation of Marketing Authorization Application of Nirogacestat
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to SWTX Stock Lookup